[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grail Inc (GRAL)

Grail Inc (GRAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,252,679
  • Shares Outstanding, K 42,917
  • Annual Sales, $ 147,170 K
  • Annual Income, $ -408,350 K
  • EBIT $ -516 M
  • EBITDA $ -353 M
  • 60-Month Beta 3.22
  • Price/Sales 20.45
  • Price/Cash Flow N/A
  • Price/Book 1.20

Options Overview Details

View History
  • Implied Volatility 88.11% (+2.74%)
  • Historical Volatility 72.02%
  • IV Percentile 40%
  • IV Rank 44.28%
  • IV High 114.54% on 10/30/25
  • IV Low 67.09% on 09/04/25
  • Expected Move (DTE 7) 4.59 (6.38%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 219
  • Volume Avg (30-Day) 522
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 23,260
  • Open Int (30-Day) 23,267
  • Expected Range 67.41 to 76.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-2.91
  • Number of Estimates 2
  • High Estimate $-2.84
  • Low Estimate $-2.98
  • Prior Year $-3.18
  • Growth Rate Est. (year over year) +8.49%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.12 +26.05%
on 06/16/26
76.07 -5.35%
on 07/10/26
+13.41 (+22.89%)
since 06/10/26
3-Month
45.14 +59.50%
on 04/13/26
79.50 -9.43%
on 05/28/26
+26.37 (+57.79%)
since 04/10/26
52-Week
29.95 +140.40%
on 08/20/25
118.84 -39.41%
on 01/22/26
+28.61 (+65.94%)
since 07/10/25

Most Recent Stories

More News
Robbins LLP Urges GRAL Stockholders to Contact the Firm for Information About the Class Action Against Grail, Inc.

San Diego, California--(Newsfile Corp. - July 10, 2026) - Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grail, Inc. (NASDAQ:...

GRAL : 72.00 (-5.00%)
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 9, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Grail, Inc. ("Grail" or the "Company") (NASDAQ: GRAL ) have opportunity...

GRAL : 72.00 (-5.00%)
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Grail, Inc. Securities Lawsuit - Contact Levi & Korsinsky

Key Dates and Disclosure Events Shareholders Need to Know: From Positive Top-Line Results to a 50.55% Stock Collapse, the Chronology of Grail's NHS-Galleri Trial Reveals an Escalating Pattern of Alleged...

GRAL : 72.00 (-5.00%)
Lost Money on Grail, Inc. (GRAL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

From Optimism to Disillusionment: How Investor Sentiment in Grail Shifted as NHS-Galleri Confidence Crumbled, Costing Shareholders $51.32 Per Share

GRAL : 72.00 (-5.00%)
GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss -- HBSS

SAN FRANCISCO , July 7, 2026 /PRNewswire/ -- On February 20, 2026, GRAIL, Inc. ( NASDAQ: GRAL ) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri...

GRAL : 72.00 (-5.00%)
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead the Grail Class Action Lawsuit

SAN DIEGO , July 7, 2026 /PRNewswire/ --  Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and...

GRAL : 72.00 (-5.00%)
GRAL Investment Deadline: GRAIL, Inc. Securities Fraud Class Action Focuses on Trial Results; Investors Notified of August 4 Court Deadline

A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer...

GRAL : 72.00 (-5.00%)
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit

NEW YORK , July 6, 2026 /PRNewswire/ --

GRAL : 72.00 (-5.00%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL

NEW YORK , July 2, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL). Such investors are advised...

GRAL : 72.00 (-5.00%)
GRAL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options

GRAL : 72.00 (-5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 81.78
2nd Resistance Point 78.93
1st Resistance Point 75.46
Last Price 72.00
1st Support Level 69.14
2nd Support Level 66.29
3rd Support Level 62.82

See More

52-Week High 118.84
Fibonacci 61.8% 84.88
Fibonacci 50% 74.39
Last Price 72.00
Fibonacci 38.2% 63.91
52-Week Low 29.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.